IndraLab

Statements

USP8 activates immune response. 2 / 2

| 2

reach

"Targeting USP8 enhances the efficacy of anti-PD-L1 therapy by reducing PD-L1 protein degradation and subsequently improving the activation of cytotoxic T lymphocytes and overall antitumor immunity."

38474186

➶

reach

"Inhibition of USP8 led to diminished tumor invasion, migration, and overall tumor size, enhancing anti-tumor immunity."

38638430

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP8 activates immune response. 2 / 2

INDRA sources:

Databases

Reading